103 related articles for article (PubMed ID: 26744643)
41. Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial.
Einstein MH; Takacs P; Chatterjee A; Sperling RS; Chakhtoura N; Blatter MM; Lalezari J; David MP; Lin L; Struyf F; Dubin G;
Hum Vaccin Immunother; 2014; 10(12):3435-45. PubMed ID: 25483701
[TBL] [Abstract][Full Text] [Related]
42. Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses.
Coates EE; Costner PJ; Nason MC; Herrin DM; Conant S; Herscovitch P; Sarwar UN; Holman L; Mitchell J; Yamshchikov G; Koup RA; Graham BS; Millo CM; Ledgerwood JE;
Clin Nucl Med; 2017 May; 42(5):329-334. PubMed ID: 28288041
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
Apter D; Wheeler CM; Paavonen J; Castellsagué X; Garland SM; Skinner SR; Naud P; Salmerón J; Chow SN; Kitchener HC; Teixeira JC; Jaisamrarn U; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; Bosch FX; Mindel A; de Sutter P; Hardt K; Zahaf T; Descamps D; Struyf F; Lehtinen M; Dubin G;
Clin Vaccine Immunol; 2015 Apr; 22(4):361-73. PubMed ID: 25651922
[TBL] [Abstract][Full Text] [Related]
44. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.
Raghu G; Mageto YN; Lockhart D; Schmidt RA; Wood DE; Godwin JD
Chest; 1999 Nov; 116(5):1168-74. PubMed ID: 10559072
[TBL] [Abstract][Full Text] [Related]
45. Myasthenia gravis following human papillomavirus vaccination: a case report.
Chung JY; Lee SJ; Shin BS; Kang HG
BMC Neurol; 2018 Dec; 18(1):222. PubMed ID: 30593270
[TBL] [Abstract][Full Text] [Related]
46. Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data.
Huygen F; Verschueren K; McCabe C; Stegmann JU; Zima J; Mahaux O; Van Holle L; Angelo MG
EBioMedicine; 2015 Sep; 2(9):1114-21. PubMed ID: 26501109
[TBL] [Abstract][Full Text] [Related]
47. HPV vaccine: Cervarix.
Szarewski A
Expert Opin Biol Ther; 2010 Mar; 10(3):477-87. PubMed ID: 20132062
[TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases.
Skinner SR; Apter D; De Carvalho N; Harper DM; Konno R; Paavonen J; Romanowski B; Roteli-Martins C; Burlet N; Mihalyi A; Struyf F
Expert Rev Vaccines; 2016; 15(3):367-87. PubMed ID: 26902666
[TBL] [Abstract][Full Text] [Related]
49. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
Demarteau N; Van Kriekinge G; Simon P
Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
[TBL] [Abstract][Full Text] [Related]
50. [Progress and challenges on HPV vaccination].
Yoshikawa H
Uirusu; 2009 Dec; 59(2):243-8. PubMed ID: 20218332
[TBL] [Abstract][Full Text] [Related]
51. Strategies for continuous evaluation of the benefit-risk profile of HPV-16/18-AS04-adjuvanted vaccine.
Angelo MG; Taylor S; Struyf F; Tavares Da Silva F; Arellano F; David MP; Dubin G; Rosillon D; Baril L
Expert Rev Vaccines; 2014 Nov; 13(11):1297-306. PubMed ID: 25219284
[TBL] [Abstract][Full Text] [Related]
52. Results on exposure during pregnancy from a pregnancy registry for AS04-HPV-16/18 vaccine.
López-Fauqued M; Zima J; Angelo MG; Stegmann JU
Vaccine; 2017 Sep; 35(40):5325-5330. PubMed ID: 28863867
[TBL] [Abstract][Full Text] [Related]
53. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
54. Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.
Huang LM; Puthanakit T; Cheng-Hsun C; Ren-Bin T; Schwarz T; Pellegrino A; Esposito S; Frenette L; McNeil S; Durando P; Rheault P; Giaquinto C; Horn M; Petry KU; Peters K; Azhar T; Hillemanns P; De Simoni S; Friel D; Pemmaraju S; Hezareh M; Thomas F; Descamps D; Folschweiller N; Struyf F
J Infect Dis; 2017 Jun; 215(11):1711-1719. PubMed ID: 28591778
[TBL] [Abstract][Full Text] [Related]
55. COVID-19 vaccine-associated organizing pneumonia.
Yoshikawa T; Tomomatsu K; Okazaki E; Takeuchi T; Horio Y; Kondo Y; Oguma T; Asano K
Respirol Case Rep; 2022 May; 10(5):e0944. PubMed ID: 35386579
[TBL] [Abstract][Full Text] [Related]
56. Correction to: A case of severe interstitial lung disease after COVID-19 vaccination.
Kono A; Yoshioka R; Hawke P; Iwashina K; Inoue D; Suzuki M; Narita C; Haruta K; Miyake A; Yoshida H; Tosaka N
QJM; 2022 Oct; 115(10):705. PubMed ID: 35312768
[No Abstract] [Full Text] [Related]
57. Adverse event monitoring of the human papillomavirus vaccines in Scotland.
Cameron RL; Ahmed S; Pollock KG
Intern Med J; 2016 Apr; 46(4):452-7. PubMed ID: 26765074
[TBL] [Abstract][Full Text] [Related]
58. Adverse events following HPV vaccination, Alberta 2006-2014.
Liu XC; Bell CA; Simmonds KA; Svenson LW; Russell ML
Vaccine; 2016 Apr; 34(15):1800-5. PubMed ID: 26921782
[TBL] [Abstract][Full Text] [Related]
59. WITHDRAWN: Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.
Inbar R; Weiss R; Tomljenovic L; Arango MT; Deri Y; Shaw CA; Chapman J; Blank M; Shoenfeld Y
Vaccine; 2016 Jan; ():. PubMed ID: 26778424
[TBL] [Abstract][Full Text] [Related]
60. Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines.
Van Damme P; Bonanni P; Bosch FX; Joura E; Kjaer SK; Meijer CJ; Petry KU; Soubeyrand B; Verstraeten T; Stanley M
Vaccine; 2016 Feb; 34(6):757-61. PubMed ID: 26772631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
